The table below shows Chemomab Therapeutics Ltd.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2023
Q1 2022
Q1 2021
Q1 2020
Q1 2019
Operating cash flow
-$7.19M
-$3.71M
-$1.29M
-$1.91M
-$3.12M
Capital expenditure
$1.00K
$14.00K
$3.00K
$10.00K
$75.00K
Investing cash flow
$14.43M
$2.38M
-$2.00K
-$10.00K
-$75.00K
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
CMMB operating cash flow (10-K history)
Chemomab Therapeutics Ltd. reported operating cash flow of -$11.13M for fiscal year 2025. That is up 27.7% from -$15.39M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$14.22M (FY 2018) to -$11.13M. Figures come from the company's audited annual reports as filed with the SEC.